| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/25/2014 | US8658795 Pyridinium boronic acid quenchers for use in analyte sensors |
| 02/25/2014 | US8658774 Meditopes and related meditope-monoclonal antibody delivery systems, synthesis and therapeutic uses thereof |
| 02/25/2014 | US8658762 Polypeptides that inhibit dopamine D2 receptor-DISC1 interaction and methods of use thereof |
| 02/25/2014 | US8658607 Immunostimulatory G, U-containing oligoribonucleotides |
| 02/25/2014 | US8658596 Biglycan and related therapeutics and methods of use |
| 02/25/2014 | US8658594 Peptide inhibitors of protein kinase C |
| 02/25/2014 | US8658434 Fluorescent pyrene compounds |
| 02/25/2014 | US8658433 Dye compounds as photoactive agents |
| 02/25/2014 | US8658432 Si/Si3N4 system nanosized particles, biosubstance labeling agent employing the nanosized particles, and method of manufacturing the nanosized particles |
| 02/25/2014 | US8658431 Determination of pregnancy status in ungulate ruminants |
| 02/25/2014 | US8658429 Photoluminescent oxygen probe tack |
| 02/25/2014 | US8658427 Means and methods for assessing increased peroxisomal proliferation |
| 02/25/2014 | US8658396 Screening method for protein variants using mass spectrometry |
| 02/25/2014 | US8658390 Method for detecting muscle degenerative diseases, and method for determining therapeutic efficacy on the diseases |
| 02/25/2014 | US8658389 Antibody conjugates |
| 02/25/2014 | US8658388 Antibody-based arrays for detecting multiple signal transducers in rate circulating cells |
| 02/25/2014 | US8658387 Ehrlichia canis DIVA (differentiate infected from vaccinated animals) |
| 02/25/2014 | US8658386 Hybridomas producing highly specific monoclonal antibodies to detect mycobacterium avium subspecies paratuberculosis |
| 02/25/2014 | US8658385 Purinergic (P2X) receptors in extra-cellular body fluid |
| 02/25/2014 | US8658384 Biomarkers for prediction of major adverse cardiac events and uses thereof |
| 02/25/2014 | US8658383 Sweet taste receptor-expressing construct, cell body expressing the same, and utilization thereof |
| 02/25/2014 | US8658382 Proteins with pteridine glycosyltransferase activity and analysis method using the same |
| 02/25/2014 | US8658381 Detection conjugate |
| 02/25/2014 | US8658380 Diagnostic and therapeutic target |
| 02/25/2014 | US8658379 Follistatin-like protein-1 as a biomarker for sepsis |
| 02/25/2014 | US8658377 Detecting cancer with anti-CCL25 and anti-CCR9 antibodies |
| 02/25/2014 | US8658376 DEK as a urine based biomarker for bladder cancer |
| 02/25/2014 | US8658375 Compositions and methods for diagnosing and treating an inflammation |
| 02/25/2014 | US8658374 Binding of aggregated forms of proteins |
| 02/25/2014 | US8658373 Method of screening for an agent for treating arthritis and promoting growth of articular chondrocytes |
| 02/25/2014 | US8658372 Affinity-based detection of biological targets |
| 02/25/2014 | US8658368 Microfabricated crossflow devices and methods |
| 02/25/2014 | US8658367 Microfabricated crossflow devices and methods |
| 02/25/2014 | US8658361 Ultra sensitive method for in situ detection of nucleic acids |
| 02/25/2014 | US8658357 Orotate transporter encoding marker genes |
| 02/25/2014 | US8658350 Methods for detecting Mycobacterium tuberculosis disease |
| 02/25/2014 | US8658168 Compositions and methods for homoconjugates of antibodies which induce growth arrest of apoptosis of tumor cells |
| 02/25/2014 | US8658134 Fibroblast growth patterns for diagnosis of Alzheimer's disease |
| 02/25/2014 | US8658133 Methods and compositions relating to alzheimer's disease |
| 02/25/2014 | US8658112 Microfluidic chip capable of synthesizing radioactively labeled molecules on a scale suitable for human imaging with positron emission tomography |
| 02/25/2014 | US8658108 Limited-use blood glucose meters |
| 02/25/2014 | US8658037 Method for determining physiological state of microbial community and wastewater treatment method |
| 02/25/2014 | US8656794 Apparatus for dissolution experiment of mineral |
| 02/25/2014 | CA2666588C Methods for the detection and diagnosis of trypanosoma cruzi infection |
| 02/25/2014 | CA2651954C Hla alleles associated with adverse drug reactions and methods for detecting such |
| 02/25/2014 | CA2629438C Human bnp immunospecific antibodies |
| 02/25/2014 | CA2628399C Methods for the determination of antibody igg avidity, by comparing liquid to solid phase avidity |
| 02/25/2014 | CA2624590C Compositional analysis of separated vapor and liquid phases using a gas chromatograph |
| 02/25/2014 | CA2609271C Novel substrate for rpn 11 enzymatic activity |
| 02/25/2014 | CA2581204C Aminolevulinic acid compounds for diagnosing tumors |
| 02/25/2014 | CA2538252C 4'-thionucleosides and oligomeric compounds |
| 02/25/2014 | CA2507936C Prion protein ligands and methods of use |
| 02/25/2014 | CA2506654C Method of detecting gene mutation |
| 02/25/2014 | CA2505325C Stabilized single domain antibodies |
| 02/23/2014 | CA2824851A1 Magnetic resonance examination of porous samples |
| 02/21/2014 | CA2823927A1 Method for performing a biochemical analysis, especially in outer space |
| 02/21/2014 | CA2813913A1 System for analysing and categorizing a geological drill core sample |
| 02/20/2014 | WO2014028939A2 Targeting phosphofructokinase and its glycosylation form for cancer |
| 02/20/2014 | WO2014028925A1 Gene expression profile associated with prostate cancer |
| 02/20/2014 | WO2014028907A1 Diagnostic markers of indolent prostate cancer |
| 02/20/2014 | WO2014028875A1 Methods for predicting risk of developing hypertension |
| 02/20/2014 | WO2014028865A1 Compositions and methods for detecting complement activation |
| 02/20/2014 | WO2014028862A1 Use of dna in circulating exosomes as a diagnostic marker for metastasic disease |
| 02/20/2014 | WO2014028852A1 Use of p47 from plasmodium falciparum (pfs47) or plasmodium vivax (pvs47) as a vaccine or drug screening targets for the inhibition of human malaria transmission |
| 02/20/2014 | WO2014028771A1 Iterative genome assembler |
| 02/20/2014 | WO2014028737A1 Diabetic animal model for diabetes research |
| 02/20/2014 | WO2014028734A1 Human ex vivo skin model and use in methods of identifying modulators of skin inflammation |
| 02/20/2014 | WO2014028726A1 Compositions and methods for the detection of bacterial infections assciated with lyme disease |
| 02/20/2014 | WO2014028687A1 Diagnostic device and method for sensing hydration state of mammalian subject |
| 02/20/2014 | WO2014028509A2 Thrombopoietin mimetics for the treatment of radiation or chemical induced bone marrow injury |
| 02/20/2014 | WO2014028494A1 Detecting and treating liver damage |
| 02/20/2014 | WO2014028445A2 Cereblon isoforms and their use as biomarkers for therapeutic treatment |
| 02/20/2014 | WO2014028416A1 Milk glycans, arrays, compositions and uses related thereto |
| 02/20/2014 | WO2014028382A1 Methods and systems for screening compositions comprising non-anticoagulant sulfated polysaccharides |
| 02/20/2014 | WO2014028328A1 Dehydration device and methods for drying biological materials |
| 02/20/2014 | WO2014027964A1 Universal biosensing and bioassay devices |
| 02/20/2014 | WO2014027899A1 NT-proCNP AS A BIOMARKER OF VASCULAR DISORDERS AND PREGNANCY COMPLICATION |
| 02/20/2014 | WO2014027831A1 Bladder cancer prognosis diagnostic marker |
| 02/20/2014 | WO2014027701A1 Methods of prognosis and diagnosis of cancer |
| 02/20/2014 | WO2014027668A1 Reelin decomposition using adamts-3 |
| 02/20/2014 | WO2014027626A1 MONOCLONAL IgE ANTIBODY BONDING TO SWEAT ALLERGY ANTIGEN PROTEIN |
| 02/20/2014 | WO2014027473A1 Stable isotope-labeled aliphatic amino acid and nmr structural analysis of protein using same |
| 02/20/2014 | WO2014027351A1 A programmable nor-based device for transcription profile analyses |
| 02/20/2014 | WO2014027281A1 Use of antioxidants in methods and means for detection of target molecules in a blood sample |
| 02/20/2014 | WO2014027196A2 Physical property modelling |
| 02/20/2014 | WO2014027188A1 Kidney disease biomarker |
| 02/20/2014 | WO2014027149A1 Composition of conjugates and uses |
| 02/20/2014 | WO2014027130A1 An electroactive material capable of anchoring lectin proteins and electrodes comprising said material |
| 02/20/2014 | WO2014027082A1 Enhanced rapid immunogen selection method for hiv gp120 variants |
| 02/20/2014 | WO2014026991A1 Biomarkers for type 2 diabetes |
| 02/20/2014 | WO2014026968A1 Protein specific optical detection |
| 02/20/2014 | WO2014026954A1 Liquid factor viii formulations |
| 02/20/2014 | WO2014026950A1 Methods and reagents for prevention and/or treatment of transplant rejection |
| 02/20/2014 | WO2014026905A1 Complex-specific antibodies and antibody fragments and its use |
| 02/20/2014 | WO2014026733A1 Device for determining particulate contamination in fluids |
| 02/20/2014 | WO2014026697A1 Device for monitoring spatial coagulation of blood and of components thereof |
| 02/20/2014 | WO2014026401A1 System for monitoring gas and gas monitor |
| 02/20/2014 | WO2014026277A1 Method for identifying novel minor histocompatibility antigens |
| 02/20/2014 | WO2014004587A3 Protein detection using fet |
| 02/20/2014 | WO2014001527A3 Lipid analysis |